Product Information
BUDESONIDE 2 MG RECTAL FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $9.5487 per GM under NDC 45802062786. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Apr 12, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802062786
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
RECTAL
Effective Date
8/19/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215328FDA Approved
4/12/2023
TE Code
AB
On Market Since
4/17/2023
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 2 MG RECTAL FOAM has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5487 per GM |
|---|---|
| All-time high | $9.5487 (Aug 19, 2026) |
| All-time low | $7.0795 (Aug 21, 2024) |
| 52-week high | $9.5487 |
| 52-week low | $9.3010 |
| Median price | $9.2370 |
| Average price | $8.8248 |
| Largest weekly change | +6.7% (Oct 23, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUDESONIDE 2 MG RECTAL FOAM?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 2 MG RECTAL FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $9.5487 per GM (NDC 45802062786), effective Aug 19, 2026.
How has the price of BUDESONIDE 2 MG RECTAL FOAM changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 2 MG RECTAL FOAM has risen 15.6%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 2 MG RECTAL FOAM?
Since Apr 17, 2024, the NADAC for BUDESONIDE 2 MG RECTAL FOAM has ranged from a low of $7.0795 (Aug 21, 2024) to a high of $9.5487 (Aug 19, 2026), with a median of $9.2370 per GM.
Are there cheaper alternatives to BUDESONIDE 2 MG RECTAL FOAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE 2 MG RECTAL FOAM, is $9.4092 per GM — about 1% below BUDESONIDE 2 MG RECTAL FOAM.
Who manufactures BUDESONIDE 2 MG RECTAL FOAM?
BUDESONIDE 2 MG RECTAL FOAM (NDC 45802062786) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.